BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17432017)

  • 1. Role of misoprostol for therapeutic termination of pregnancy from 10 -28 weeks of gestation.
    Naz S; Sultana N
    J Pak Med Assoc; 2007 Mar; 57(3):129-32. PubMed ID: 17432017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination.
    Mahjabeen ; Khawaja NP; Rehman R
    J Coll Physicians Surg Pak; 2009 Jun; 19(6):359-62. PubMed ID: 19486574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy.
    Zangeneh M; Malek-Khosravi S; Veisi F; Rezavand N; Rezaee M; Rajatee M
    Int J Gynaecol Obstet; 2012 Apr; 117(1):78-80. PubMed ID: 22261129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol for uterine evacuation in patients with early pregnancy failures.
    Murchison A; Duff P
    Am J Obstet Gynecol; 2004 May; 190(5):1445-6. PubMed ID: 15167864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
    Ting WH; Peng FH; Lin HH; Lu HF; Hsiao SM
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral misoprostol in the prevention of uterine bleeding after surgical evacuation of first trimester abortion: a comparative study of three uterotonic agents.
    Aramide TM; Olusegun AK; Akinfolarin AC; Oriola DF
    Niger J Clin Pract; 2014; 17(1):10-3. PubMed ID: 24326799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.
    Ho PC; Blumenthal PD; Gemzell-Danielsson K; Gómez Ponce de León R; Mittal S; Tang OS
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S178-81. PubMed ID: 17961566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic termination of second trimester pregnancy with vaginal misoprostol.
    Pongsatha S; Tongsong T; Suwannawut O
    J Med Assoc Thai; 2001 Apr; 84(4):515-9. PubMed ID: 11460962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised trial of two regimens of vaginal misoprostol to manage termination of pregnancy of up to 16 weeks.
    Khazardoost S; Hantoushzadeh S; Madani MM
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):226-9. PubMed ID: 17550491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.